🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This multicenter, open-label, Phase I study will evaluate the safety, effic...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2015-07-22
Trial ID
NCT02431208
The purpose of this first-in-human study is to evaluate the safety, tolerab...
Status
Recruiting
Location
City of Hope National Medical Center
Start Date
2025-07-31
Trial ID
NCT07094113
Treatments Being Tested
This study has 2 parts: a Dose Escalation Part and a Dose Expansion Part. ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2017-10
Trial ID
NCT03283046
Treatments Being Tested
B-cell Lymphoma is an aggressive and rare cancer of a type of immune cell (...
Status
Active Not Recruiting
Location
The University of Arizona Cancer Center - North Campus /ID# 242219
Start Date
2022-06-14
Trial ID
NCT05283720
The purpose of this study is to find a safe, tolerable, and efficacious dos...
Status
Terminated
Location
Local Institution - 0047
Start Date
2023-11-09
Trial ID
NCT06024174
Treatments Being Tested
This is an open label clinical study: Phase Ia is a dose escalation phase, ...
Status
Recruiting
Location
The First Affiliated Hospital, School of Medicine, Zhejiang University
Start Date
2025-07-01
Trial ID
NCT07073833
Treatments Being Tested
This is a first-in-human, Phase I, open-label, multicenter, multinational s...
Status
Recruiting
Location
South Texas Accelerated Research Therapeutics (START) Midwest
Start Date
2025-06-05
Trial ID
NCT07030959
This is a first-in-human (FIH) study to evaluate the safety and tolerabilit...
Status
Recruiting
Location
University of California San Diego
Start Date
2021-08-18
Trial ID
NCT05007782
Treatments Being Tested
A Phase 1, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolera...
Status
Terminated
Location
UCLA
Start Date
2016-05-01
Trial ID
NCT02519270
Treatments Being Tested
Background: Adult T-cell leukemia/lymphoma (ATLL) and mycosis fungoides/Se...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
2020-02-26
Trial ID
NCT04185220
Treatments Being Tested